Vanguard Personalized Indexing Management
GILD icon

Vanguard Personalized Indexing Management’s Gilead Sciences GILD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7M Sell
211,436
-1,595
-0.7% -$210K 0.22% 68
2026
Q1 		$29.7M Buy
213,031
+8,983
+4% +$1.26M 0.29% 49
2025
Q4 		$25M Buy
204,048
+4,888
+2% +$594K 0.24% 62
2025
Q3 		$22.1M Buy
199,160
+5,132
+3% +$583K 0.23% 69
2025
Q2 		$21.5M Buy
194,028
+31,712
+20% +$3.37M 0.24% 64
2025
Q1 		$18.2M Buy
162,316
+12,099
+8% +$1.25M 0.27% 59
2024
Q4 		$13.9M Buy
150,217
+9,316
+7% +$839K 0.21% 74
2024
Q3 		$11.8M Buy
140,901
+34,995
+33% +$2.67M 0.19% 87
2024
Q2 		$7.26M Sell
105,906
-2,763
-3% -$184K 0.14% 120
2024
Q1 		$7.96M Sell
108,669
-2,876
-3% -$221K 0.17% 99
2023
Q4 		$9.04M Sell
111,545
-229
-0.2% -$17.8K 0.23% 68
2023
Q3 		$8.38M Buy
111,774
+15,889
+17% +$1.22M 0.25% 60
2023
Q2 		$7.39M Buy
95,885
+9,015
+10% +$719K 0.23% 72
2023
Q1 		$7.21M Buy
86,870
+9,540
+12% +$790K 0.25% 67
2022
Q4 		$6.64M Buy
77,330
+8,080
+12% +$640K 0.27% 59
2022
Q3 		$4.27M Buy
69,250
+17,577
+34% +$1.11M 0.19% 87
2022
Q2 		$3.19M Buy
51,673
+22,326
+76% +$1.38M 0.15% 122
2022
Q1 		$1.74M Sell
29,347
-4,016
-12% -$257K 0.08% 227
2021
Q4 		$2.42M Buy
33,363
+4,363
+15% +$301K 0.14% 123
2021
Q3 		$2.03M Buy
29,000
+4,806
+20% +$338K 0.18% 107
2021
Q2 		$1.67M Buy
24,194
+6,889
+40% +$460K 0.17% 118
2021
Q1 		$1.12M Buy
17,305
+5,357
+45% +$345K 0.17% 126
2020
Q4 		$696K Buy
11,948
+1,082
+10% +$65.3K 0.15% 156
2020
Q3 		$687K Buy
10,866
+382
+4% +$26.5K 0.19% 127
2020
Q2 		$807K Buy
10,484
+884
+9% +$67.7K 0.37% 57
2020
Q1 		$718K Buy
+9,600
New +$663K 0.42% 64

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Personalized Indexing Management's GILD Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Gilead Sciences (GILD) stake by 0.75% in Q2 2026, selling an estimated $210K and leaving 211,436 shares worth $26.7M. The position accounts for 0.22% of the portfolio, ranked #68.

Vanguard Personalized Indexing Management first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $29.7M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vanguard Personalized Indexing Management held 211,436 shares of Gilead Sciences worth $26.7M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 1,595 Gilead Sciences shares in Q2 2026, an estimated $210K.
  • Gilead Sciences made up 0.22% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #68 holding.
  • Vanguard Personalized Indexing Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • Vanguard Personalized Indexing Management's Gilead Sciences position peaked at $29.7M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.